Risk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA.2) Period in Korea
Open Access
- 1 January 2023
- journal article
- research article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (34) , e269
Abstract
Lee JH, et al. J Korean Med Sci. 2023 Aug;38(34):e269. https://doi.org/10.3346/jkms.2023.38.e269Keywords
This publication has 15 references indexed in Scilit:
- Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in SwedenThe Lancet Regional Health - Europe, 2022
- Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing ReinfectionJAMA Network Open, 2022
- Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South AfricaScience, 2022
- Reinfection in patients with COVID-19: a systematic reviewGlobal Health Research and Policy, 2022
- Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide SettingNew England Journal of Medicine, 2022
- Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022Eurosurveillance, 2022
- Disease severity during SARS-COV-2 reinfection: a nationwide studyJournal of Infection, 2022
- Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South AfricaJournal of Medical Virology, 2021
- Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- A simple method for estimating relative risk using logistic regressionBMC Medical Research Methodology, 2012